Wells syndrome, also called eosinophilic cellulitis, is an uncommon inflammatory skin condition in which a type of white blood cell called an eosinophil floods the skin and causes red, swollen, sometimes blistering lesions that look remarkably like a bacterial skin infection but do not respond to antibiotics. The condition was first described in the 1970s, and because it remains rare and shape-shifting in its appearance, many people cycle through multiple misdiagnoses before getting the right one. Understanding what triggers it, how doctors confirm it, and what actually helps is more nuanced than most dermatology textbook summaries suggest.
What Wells Syndrome Looks Like
The hallmark of Wells syndrome is skin inflammation that mimics bacterial cellulitis: warm, painful, swollen patches that can appear suddenly and spread over hours to days. But beyond that classic look, the condition wears many disguises. Patients can develop blisters, firm nodules, raised papules, ring-shaped (annular) plaques, or urticaria-like wheals. Some people get a single patch; others break out in multiple areas simultaneously. Fever, joint pain, and general malaise sometimes accompany the skin findings.1PubMed Central. Diagnosis and management of eosinophilic cellulitis (Wells’ syndrome): A case series and literature review
A study of 19 patients found at least seven distinct clinical variants. In children, the classic plaque-type lesion was most common, while adults more often presented with annular ring-shaped patches resembling a completely different condition called granuloma annulare. Blisters appeared in some adults but were not seen in children at all. And to complicate things further, different lesion types can show up on the same person at the same time, especially as the disease progresses.2JAMA Dermatology. Wells Syndrome in Adults and Children: A Report of 19 Cases
Each individual episode typically resolves on its own within about four to six weeks. As the active inflammation fades, the affected skin often leaves behind temporary discoloration, usually a brownish or grayish tint that can last weeks to months before clearing. This self-limited course is one of the key features distinguishing Wells syndrome from true bacterial cellulitis, which generally worsens without antibiotics rather than improving spontaneously.
What Triggers It
In many cases, no clear trigger is ever found, which is one of the more frustrating aspects of the disease. When triggers can be identified, they fall into a few broad categories: insect bites, medications, infections, and occasionally underlying blood cancers.
Insect bites are among the longest-recognized triggers and may set off initial or recurrent episodes.3PubMed. Wells’ syndrome, insect bites, and eosinophils The drug list is broad and keeps growing. Antibiotics, nonsteroidal anti-inflammatory drugs (NSAIDs), anesthetics, thyroid medications, chemotherapy agents, and thiazide diuretics have all been linked to flares.4PubMed Central. Wells syndrome (eosinophilic cellulitis): Proposed diagnostic criteria and a literature review of the drug-induced variant One case report described a patient who developed the syndrome two days after starting amoxicillin for a dental abscess while already taking NSAIDs.5International Journal of Dermatology. Drugs and Wells’ syndrome: a possible causal relationship?
More recently, COVID-19 infection, SARS-CoV-2 vaccines, influenza vaccines, certain pediatric vaccines containing aluminum or gelatin, and biologic therapies like ustekinumab and TNF-alpha inhibitors have been identified as triggers. In vaccine-related cases, patch testing has supported a causal link rather than coincidence.6PubMed Central. Wells syndrome: emerging triggers and treatments– an updated systematic review One report described a woman with chronic lymphocytic leukemia who developed Wells syndrome ten days after an influenza vaccination, with the situation further complicated by her ongoing treatment with the drug ibrutinib.7PubMed Central. Wells’ syndrome possibly caused by hematologic malignancy, influenza vaccination or ibrutinib: A case report
Fungal infections are an underappreciated trigger. In one case, a woman had recurrent blistering lesions on her feet for a year that failed to respond to steroids, antibiotics, and methotrexate. Her Wells syndrome turned out to be driven by athlete’s foot and toenail fungus; treating the fungal infection with oral terbinafine resolved both the fungus and the recurring skin eruptions.8PubMed Central. Breaking the Blister: A Case Report of Bullous Wells’ Syndrome Resolved with Oral Terbinafine Blood cancers, particularly chronic lymphocytic leukemia, have also been associated with the condition, sometimes revealing themselves only after dermatologists investigate the skin disease.9PubMed Central. Wells syndrome associated with chronic lymphocytic leukemia
Why the Immune System Overreacts
Wells syndrome is fundamentally a disease of eosinophils behaving badly. Eosinophils are immune cells that normally help fight parasites and regulate inflammation, but in this condition they accumulate in the skin in large numbers and release their granule contents into the surrounding tissue. The protein most closely linked to tissue damage is eosinophil cation protein (ECP), a toxic substance that eosinophils dump when they degranulate.
Research has pointed to interleukin-5 (IL-5) as a central driver. IL-5 is a signaling molecule that promotes eosinophil growth, survival, and activation. In patients with Wells syndrome, IL-5 levels in the blood and tissues rise and fall in close step with disease activity: high during flares, low during remission.10British Journal of Dermatology. Wells’ syndrome (eosinophilic cellulitis): correlation between clinical activity, eosinophil levels, eosinophil cation protein and interleukin‐5
Another piece of the puzzle involves interleukin-2 (IL-2). In patients with excess eosinophils, some of those cells express a receptor called CD25 on their surface. When IL-2 binds to that receptor at sites of inflammation, it primes the eosinophils to degranulate more aggressively. Patients whose eosinophils have higher CD25 expression appear to be at greater risk for tissue damage.11PubMed. Interleukin-2 primes eosinophil degranulation in hypereosinophilia and Wells’ syndrome This helps explain why two people with the same eosinophil count can have very different outcomes: it is not just how many eosinophils show up, but how easily they are triggered to unload their toxic cargo.
How Doctors Confirm the Diagnosis
There is no single blood test that definitively confirms Wells syndrome, which is part of why it is often diagnosed late. Most patients have elevated eosinophil counts on a standard blood test, but that finding is nonspecific and can accompany allergies, parasitic infections, drug reactions, and many other conditions. The diagnosis ultimately rests on a skin biopsy, interpreted alongside the clinical picture.
Under the microscope, the biopsy typically progresses through three phases. In the acute phase, the upper and middle layers of the skin are swollen and packed with eosinophils, but without the blood vessel inflammation you would see in vasculitis. In the subacute phase, the tissue develops what pathologists call “flame figures,” which are the single most distinctive finding in Wells syndrome. In the regressive phase, the eosinophils gradually disappear, replaced by other immune cells forming small clusters around damaged collagen.12JAMA Dermatology. Wells Syndrome in Adults and Children: A Report of 19 Cases
Flame figures get their name from their appearance: bright red, flame-shaped deposits surrounding collagen fibers. Electron microscopy has shown that these figures consist of free eosinophil granules coating the collagen fibers, essentially debris left behind after eosinophils have emptied their contents. Despite how dramatic they look, the collagen itself does not appear to be damaged in most cases.13PubMed. Wells’ syndrome: is there collagen damage in the flame figures? However, flame figures are found in only about half of biopsied cases, so their absence does not rule out Wells syndrome.14JAMA Dermatology. Wells Syndrome in Adults and Children: A Report of 19 Cases And they are not entirely unique to this disease; flame figures occasionally appear in other eosinophil-rich conditions, though they tend to be more prominent and widespread in Wells syndrome than in mimics.
Because no universally accepted set of diagnostic criteria exists, diagnosis often happens by exclusion. Doctors need to rule out bacterial cellulitis (which would show bacteria and neutrophils rather than eosinophils on biopsy), drug hypersensitivity reactions, contact dermatitis, urticarial vasculitis, hypereosinophilic syndrome, and parasitic infections. When the clinical presentation is ambiguous, the response to treatment can serve as an additional clue: Wells syndrome responds to steroids but not to antibiotics, while the reverse is true for bacterial cellulitis.
Treatment Options
Since episodes can resolve on their own, treatment decisions depend on how bothersome the symptoms are and how frequently they recur. For mild or localized flares, topical corticosteroids applied directly to the affected skin may be enough. One case report documented rapid healing with topical steroids, with only one relapse over the following year, which responded to the same treatment.15Journal of the European Academy of Dermatology and Venereology. Eosinophilic cellulitis (Wells’ syndrome): a new case description
For more severe or widespread disease, oral corticosteroids like prednisolone are the most commonly used first-line treatment and have the highest reported success rates. One review estimated that systemic steroids clear the skin in roughly nine out of ten cases. Topical corticosteroids and antihistamines are considerably less effective when used alone, succeeding in about half and a quarter of cases respectively.16PubMed Central. A case report of recurrent Well’s syndrome masquerading as cellulitis
The catch with oral steroids is that many patients relapse when the dose is tapered, creating a cycle of flare, steroid course, improvement, taper, and relapse. Long-term or repeated steroid use brings its own set of problems: weight gain, thinning skin, elevated blood sugar, bone loss, and increased infection risk. For patients who become steroid-dependent, a systematic review found a wide array of steroid-sparing alternatives that have been tried, including cyclosporine, dapsone, azathioprine, colchicine, doxycycline, and even light therapy (PUVA).17PubMed. Treatment of eosinophilic cellulitis (Wells syndrome) – a systematic review
Among those alternatives, cyclosporine has some of the better-documented success. One patient who kept relapsing whenever prednisolone was reduced was switched to cyclosporine and maintained clear skin without further flares even after the cyclosporine was eventually stopped.18PubMed Central. Successful treatment of steroid-dependent eosinophilic cellulitis with cyclosporine Because the evidence base consists mostly of individual case reports and small series rather than large trials, there is no single standardized second-line protocol. Treatment tends to be tailored through trial and error.
When a specific trigger can be identified, treating or removing that trigger may be the most effective strategy of all. The patient whose Wells syndrome was driven by a fungal foot infection saw her recurrent blistering episodes stop entirely once the fungus was eradicated with terbinafine, without any need for ongoing immunosuppression.19PubMed Central. Breaking the Blister: A Case Report of Bullous Wells’ Syndrome Resolved with Oral Terbinafine Similarly, if a drug is the suspected culprit, discontinuing it may prevent future episodes.
Children Versus Adults
Wells syndrome affects both children and adults, but the experience is somewhat different depending on age. Children tend to get single lesions in the classic plaque form, while adults are more likely to develop multiple lesions in varied forms, including the annular and bullous variants. Adults also have more frequent episodes over a longer disease course, averaging about four relapses compared to about three in children.20JAMA Dermatology. Wells Syndrome in Adults and Children: A Report of 19 Cases
In children, insect bites are a particularly common trigger, and pediatric cases are more often self-limited with fewer recurrences. The practical implication is that a child with a confirmed diagnosis and a clear insect-bite trigger may need only supportive care and close follow-up, while an adult with recurrent multi-site disease is more likely to require systemic treatment and a thorough search for an underlying cause.
Recurrence and Long-Term Outlook
Wells syndrome is not dangerous in the way that a serious infection or cancer is, but it is unpredictable. The estimated recurrence rate sits around 56%, based on a case series of 32 patients.21PubMed Central. A case report of recurrent Well’s syndrome masquerading as cellulitis Some people have a single episode and never see it again. Others experience recurrences for years or even decades, with variable intervals between flares. The disease does not cause scarring in most cases, though persistent or frequently recurring lesions can leave lasting discoloration.
One meaningful long-term consideration is the small but real association with hematologic malignancies, particularly chronic lymphocytic leukemia.22PubMed. Case of Wells’ syndrome: A rare association with the clinical course of chronic lymphocytic leukemia This does not mean that most people with Wells syndrome have cancer; the association is uncommon. But it does mean that adults diagnosed with recurrent eosinophilic cellulitis, especially if no other trigger is apparent, should have a basic blood workup to screen for underlying blood disorders. In some reported cases, the skin disease was the first sign that led to the discovery of an occult leukemia.23PubMed Central. Wells syndrome associated with chronic lymphocytic leukemia
Why It Gets Misdiagnosed So Often
Wells syndrome has earned a reputation as a diagnostic chameleon, and for good reason. The acute presentation, with hot, red, swollen, painful skin, looks virtually identical to bacterial cellulitis. Since bacterial cellulitis is common and Wells syndrome is rare, the first instinct of most emergency department physicians is to prescribe antibiotics. When the lesions resolve on their own (as they were going to do anyway), the antibiotics get the credit, and the diagnosis is never questioned. It is usually only when the same person keeps coming back with “cellulitis” that does not respond to antibiotics, or that keeps returning despite adequate treatment, that someone considers an alternative explanation.
The annular variant can mimic granuloma annulare, tinea corporis (ringworm), or even early Lyme disease. Bullous variants can be confused with autoimmune blistering diseases like bullous pemphigoid. And because eosinophil-rich inflammation in the skin can show up in drug reactions, parasitic infections, and hypereosinophilic syndrome, even dermatologists who suspect the right neighborhood sometimes struggle to pin down the exact address. The absence of flame figures in roughly half of biopsied cases further complicates things.
If you or someone you know has been treated for cellulitis multiple times with incomplete or short-lived improvement, or if swollen skin patches keep recurring without a clear infectious source, raising the possibility of Wells syndrome with your doctor is reasonable. A skin biopsy with specific attention to eosinophilic infiltration is the key step that separates this condition from its many mimics.
Emerging Research Directions
Because Wells syndrome is so rare, the research literature consists almost entirely of case reports and small case series rather than randomized controlled trials. This makes it difficult to establish evidence-based treatment guidelines with any real confidence. The systematic reviews that do exist acknowledge this limitation and largely catalog what has been tried rather than what has been proven.
The identification of IL-5 as a central mediator has opened up a theoretical treatment avenue. Biologic drugs that block IL-5, originally developed for severe eosinophilic asthma, are now being explored in case reports for Wells syndrome. The logic is straightforward: if IL-5 drives the eosinophil accumulation and activation that cause the disease, blocking it should help. Early reports are promising but far too limited to draw firm conclusions. The updated systematic review covering 2016 through 2025 documented several newly recognized triggers, including COVID-19 and newer biologic therapies, highlighting that the list of known precipitants continues to expand as clinical awareness grows.24PubMed Central. Wells syndrome: emerging triggers and treatments– an updated systematic review
One of the more interesting paradoxes in the field is that TNF-alpha inhibitors, which are used to treat many inflammatory skin diseases, have themselves been reported as triggers for Wells syndrome. This is a reminder that the immune pathways involved are more tangled than a simple “too much inflammation” story would suggest. Suppressing one branch of the immune system can sometimes unmask or amplify another, and eosinophilic pathways seem particularly prone to these rebound effects when the immune balance shifts.